Isibhedlela saseBeijing GoBroad

Isibhedlela saseBeijing GoBroad yisibhedlela socwaningo esigxile ekuxilongeni nasekwelapheni izimo ezinzima nezinzima, ukwenza ucwaningo lwezempilo, kanye nokulungisa kabusha izimboni ze-biomedicine nezisetshenziswa zezokwelapha. Ihlinzeka ngenkundla yesevisi yomphakathi yocwaningo lwezokwelapha ku Beijing. Sihlanganise iqembu lochwepheshe abadumile bocwaningo lwezokwelapha abavela e-China, kanye nethimba eliphelele labasekeli bocwaningo lwezokwelapha. Sakhelwa phezu kwamakhono aso ocwaningo lwezokwelapha, isibhedlela sisebenzisa isisekelo esiqinile saseBeijing ocwaningweni oluyisisekelo, amafemu amabhizinisi, nezikhungo zocwaningo ukuze kusungulwe uhlelo lwemvelo olusezingeni eliphezulu lokusungula izinto ezintsha zezokwelapha.

Njengesinye sezibhedlela ezihamba phambili ze- I-GoBroad Healthcare Group, eyasungulwa ngo-2017, i-Beijing GoBroad Hospital iyiphayona kanye nomsebenzi wephethini yesibhedlela socwaningo. Imikhakha emine yebhizinisi eyinhloko yaleli qembu yiSikhungo Sokwelapha Esiyinselele Nokunakekelwa Okubucayi, Isikhungo Sokucwaninga Ngezokwelapha, Isikhungo Sokuxilongwa Okuqondile, kanye Nesikhungo Sobuhlakani Bedatha. Inhlangano ihlanganise ochwepheshe bezokwelapha abavelele ngenhloso yokuthuthukisa ubuhlakani bezokwelapha, futhi bakhe inkundla edidiyelwe eyenza kube lula ukusebenzisana kwemboni kanye nokwelashwa.

Iningi labasebenzi lizinikele ekuhlinzekeni ngosizo lochwepheshe ukuze bashintshele ekusungulweni okusha komtholampilo. I-Early Clinical Research Center, Central Laboratory, Imaging Center, Pathology Center, Clinical Pharmacology, Clinical Evaluation Center for Cardiac Safety, Medical and Statistical Teams, njalonjalo izibonelo zamaqembu esevisi akhethekile. Selokhu yasungulwa, inkampani ikhule ngokushesha, iqongelela inqwaba yolwazi ngokusebenza namakhulu ezinkampani ezithaka imithi ezisezingeni eliphezulu nokwenza izivivinyo ezahlukahlukene. Ukwengeza, inikeze amashumi ezinkulungwane zeziguli ezinzima nezigula kakhulu ithemba elisha.

• I-leukemia;
• I-Lymphoma;
• IMyeloma:
• Isifo seMyelodysplastic (MDS);
• I-Myelodysplastic/myeloproliferative neoplasms (MDS/MPN);
• I-Thalassemia;
• I-anemia ye-aplastic;
• I-Paroxysmal nocturnal hemoglobinuria (PNH);
• I-Thrombocytopenia;
• Ukuphazamiseka kwe-blood coagulation;
• I-hemophagocytic lymphohistiocytosis;
• i-agammaglobulinemia exhunywe ku-X;
• Idiopathic neutropenia;
• I-Wiskott-Aldrich syndrome (WAS);
• Amasosha omzimba;
• Isifo se-granulomatous esingamahlalakhona;
• I-Hyperimmunoglobulin M syndrome;
• Izifo ze-Hematopoietic;
• Okunye ukuphazamiseka kwegazi.

Isibhedlela sise-Changping Life Science Park e-Beijing, esithatha indawo ecishe ibe ngamamitha-skwele ayi-100,000. Kuhlelelwe ukuthi kube nemibhede engu-500, okuhlanganisa nemibhede eyi-100 enikelwe ocwaningweni lwangaphambi kwesikhathi. Isebenza ngokukhethekile ngezimila eziqinile, izimila ze-hematological, nesayensi yobuchopho, isibhedlela savulwa ngokusemthethweni ngoJulayi 2023.

Isakhiwo 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, China – 102200

Umnyango We-Hematology 1: I-Hematology Jikelele
Uchwepheshe ohamba phambili, Tong Chun Rong uneminyaka engama-30 yokuhlangenwe nakho komtholampilo kanye nelabhorethri ezifweni ze-hematological. Umnyango uhlinzeka ngezinhlobo ezahlukene zokuxilongwa nokwelashwa kwezifo zegazi, njenge:

• i-leukemia
• i-lymphoma
• i-myeloma eminingi nezinye izimila ze-hematological;
• i-thalassemia nezinye izifo ze-anemia;
• i-thrombocytopenia nezinye izinkinga zokuvala igazi.

Umnyango ugxile ekuxilongweni okupheleleyo, ukwelashwa komuntu ngamunye kwezifo ze-hematological, nokwelashwa kwezimila ze-hematological ngezindlela ezinjengokuthi:

• imiphumela emibi yokwelashwa ngamakhemikhali
• ukwelashwa okubhekiswe
• ukwelashwa kwemisebe

Ukwengeza, umnyango ubambe iqhaza ekwakheni amasu okwelapha jikelele. Ithimba lezokwelapha lilungisa umthamo wezidakamizwa ngokusekelwe kumetabolism yazo futhi liqaphe ukugxila, liqinisekisa ukuphepha nokusebenza ngempumelelo kokwelashwa.

Umnyango We-Hematology 2: Ukufakelwa kabusha

Uchwepheshe ohamba phambili u-Wu Tong unesipiliyoni seminyaka engu-30 ekufakelweni kwe-hematopoietic stem cell. Wenze ngempumelelo ukufakelwa kwe-allogeneic engaphezu kuka-4,000.
Ithimba lomnyango linolwazi olunzulu ekusetshenzisweni kwe-hematopoietic stem cell transplantation ukwelapha ukuphazamiseka kwe-hematopoietic kanye nokuzivikela komzimba, okufana nalokhu:

• i-leukemia;
• i-myelodysplastic syndrome (MDS);
• i-myelodysplastic/myeloproliferative neoplasms (MDS/MPN);
• i-lymphoma;
• i-myeloma eminingi;
• i-anemia ye-aplastic;
• i-paroxysmal nocturnal hemoglobinuria (PNH);
• i-hemophagocytic lymphohistiocytosis (familial and Epstein-Barr virus-associated);
• i-agammaglobulinemia exhunywe ku-X;
• idiopathic neutropenia;
• I-Wiskott-Aldrich syndrome (WAS);
• ama-immunodeficiencies ahlangene kakhulu;
• isifo esingamahlalakhona se-granulomatous;
• hyperimmunoglobulin M syndrome;
• izifo zesisu ezivuvukalayo zezingane nezinye izifo zegazi.

Isigaba Se-Hematology 3: I-Lymphoma Yezingane

Uchwepheshe ohamba phambili u-Zhang Yong Hong uneminyaka engaphezu kwengama-30 yesipiliyoni somtholampilo ezifweni ze-hematologic zezingane, ikakhulukazi ekwelapheni i-lymphoma ne-leukemia. U-Zhang Yong Hong ungumqondisi wezesayensi weqembu lochwepheshe eligxile kwi-lymphoma e-Beijing Children's Hospital kanye nomqondisi ongumsunguli we-China-Net Children's Lymphoma.

The department diagnoses and treats various types of lymphomas, including lymphoblastic lymphoma, Burkitt’s lymphoma, anaplastic large-cell lymphoma, and I-lymphoma kaHodgkin. The diagnosis and treatment process involves advanced programs that take into account the different types of pathologies, risk factors, and the results of stepwise evaluation during therapy. Treatment is continuously adjusted according to the results obtained. The 5-year complication-free survival rate for all types of I-non-Hodgkin's lymphoma is more than 80% and more than 90% for Hodgkin’s lymphoma.

Umnyango We-Hematology 4: I-Lymphoma Yabantu Abadala

U-Ke Xiao Yan, uchwepheshe we-lymphoma owaziwayo, uhola umnyango. Umnyango usebenzisa uhlelo lokwelapha lwesizukulwane sesibili, oluhlanganisa imingcele yomtholampilo yeziguli ukuze uthole ukubikezela okunembe kakhudlwana nokukhetha imithi.

Ithimba lomnyango lihlola amasu amasha okwelapha iziguli ezine-refractory lymphoma. Uma ukuphinda kwenzeka ngemva kokwelashwa komuntu ngamunye, iziguli zinikezwa inkambo eyengeziwe yokwelashwa ngempumelelo engama-75%. Ezigulini ezine-lymphoma ebuyele emuva noma i-myeloma ethinta isimiso sezinzwa esimaphakathi, ukwelashwa komuntu ngamunye kusetshenziswa ngempumelelo engu-88.9%.

Ithimba lezokwelapha lidala uhlelo lokwelapha lomuntu ngamunye olusekelwe ekuxilongweni okunembile, okuhlanganisa ukwelashwa okuhlosiwe, ukwelapha ngamakhemikhali okunomthamo omkhulu, kanye nokufakelwa kwe-hematopoietic stem cell.

Ilebhu Yezokwelapha

Ilabhorethri yezokwelapha ihlanganisa indawo elinganiselwa ku-5,000 square metres futhi ithola ukutshalwa kwezimali okungaphezu kwezigidi eziyi-100 zamayuan. Ilabhorethri inethimba lochwepheshe abahamba phambili abavela emikhakheni eyahlukene abaneziqu zobudokotela neziqu. Ilabhorethri igxile ekwenzeni ukuhlolwa okubanzi komtholampilo, okufana nalokhu:

• ukuhlolwa komtholampilo okuvamile;
• i-cell morphology;
• i-cytochemistry;
• i-histopathology kanye ne-immunohistochemistry;
• ukuhlaziywa kwe-cytometry yokugeleza;
• i-fluorescence in situ hybridization (INHLANZI);
• ukuhlaziywa kwezakhi zofuzo (okuhlanganisa ukuhlaziywa kwezakhi zofuzo ze-hematological tumors, izifo zegazi zofuzo, kanye nezakhi zofuzo ezifweni zegazi, ukuhlaziywa kwezakhi zofuzo ze-metabolism yezidakamizwa, izakhi zofuzo ze-pathogenic, nokunye);
• ukuhlaziywa kwamagciwane, ukugxila kwezidakamizwa, nama-cytokines.

Lezi zivivinyo zisiza odokotela ukuthi banikeze ukwelashwa okunembe kakhudlwana nangomuntu ngamunye, ukwandisa ukusebenza kahle, ukunciphisa imiphumela emibi, nokuqeda ama-syndromes obuhlungu. Ilabhorethri yezokwelapha ibuye iqoqe, ihlukanise, futhi ilondoloze izingxenye zamangqamuzana egazi kanye namaseli e-hematopoietic stem.

Umnyango wePathoanatolical 
UDkt. Guo Li Gai uphethe umnyango futhi ugxile kakhulu ku-pathology ye-lymphatic and hematopoietic systems (i-molecular pathology). Unolwazi olunzulu ekuxilongeni izifo, ikakhulukazi i-leukemia, i-myelodysplastic syndrome (MDS), kanye ne-myelodysplastic/myeloproliferative neoplasms (MDS/MPN). Kusukela ngo-2006, udokotela ushicilele imibiko engaphezu kuka-20,000 ye-bone marrow biopsy. Kusukela ngo-2014, u-Guo Li Gai uye wafunda izinkulungwane zamacala e-lymphoma yomtholampilo futhi waqongelela ulwazi olucebile lokuxilonga izifo ze-hematologic kanye ne-lymphomas.

Ukuze kwenziwe ukuxilonga okunembile, umnyango we-pathology usungule imodeli yokuxilonga ehlanganisiwe ye-stereoscopic (MICM), ehlanganisa i-morphology (M), i-immunology (I), i-cytogenetics (C), nesayensi yamangqamuzana (M). Umnyango usebenzisana kakhulu nabakwa I-Mayo Clinic.